Literature DB >> 20661256

Inbreeding and epigenetics: beneficial as well as deleterious effects.

Daniel W Nebert, Marina Gálvez-Peralta, Zhanquan Shi, Nadine Dragin.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20661256      PMCID： PMC3025405          DOI： 10.1038/nrg2664-c2

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN： 1471-0056            Impact factor:   53.242


× No keyword cloud information.
  11 in total

Review 1.  Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases.

Authors:  Nima Mosammaparast; Yang Shi
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

Review 2.  Methods in DNA methylation profiling.

Authors:  Tao Zuo; Benjamin Tycko; Ta-Ming Liu; Juey-Jen L Lin; Tim H-M Huang
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

3.  Inbreeding effects in the epigenetic era.

Authors:  Christian Biémont
Journal:  Nat Rev Genet       Date:  2010-01-27       Impact factor: 53.242

Review 4.  Research on inbreeding in the 'omic' era.

Authors:  Torsten N Kristensen; Kamilla S Pedersen; Cornelis J Vermeulen; Volker Loeschcke
Journal:  Trends Ecol Evol       Date:  2009-09-04       Impact factor: 17.712

Review 5.  The genetics of inbreeding depression.

Authors:  Deborah Charlesworth; John H Willis
Journal:  Nat Rev Genet       Date:  2009-11       Impact factor: 53.242

Review 6.  Chromatin remodelling during development.

Authors:  Lena Ho; Gerald R Crabtree
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

7.  Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouse.

Authors:  Nadine Dragin; Zhanquan Shi; Rajat Madan; Christopher L Karp; Maureen A Sartor; Chi Chen; Frank J Gonzalez; Daniel W Nebert
Journal:  Mol Pharmacol       Date:  2008-03-27       Impact factor: 4.436

Review 8.  Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology.

Authors:  Daniel W Nebert; Christopher L Karp
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

Review 9.  Decanalization and the origin of complex disease.

Authors:  Greg Gibson
Journal:  Nat Rev Genet       Date:  2009-01-02       Impact factor: 53.242

Review 10.  Genomic screening with RNAi: results and challenges.

Authors:  Stephanie Mohr; Chris Bakal; Norbert Perrimon
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643
View more
  6 in total

1.  Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways.

Authors:  Senad Divanovic; Jesmond Dalli; Lucia F Jorge-Nebert; Christopher L Karp; Charles N Serhan; Daniel W Nebert; Leah M Flick; Marina Gálvez-Peralta; Nicholas D Boespflug; Traci E Stankiewicz; Jonathan M Fitzgerald; Maheshika Somarathna
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

2.  Concerning epigenetics and inbreeding.

Authors:  Frank Johannes; Maria Colomé-Tatché
Journal:  Nat Rev Genet       Date:  2011-03-22       Impact factor: 53.242

Review 3.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

Review 4.  Aryl hydrocarbon receptor (AHR): "pioneer member" of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of "sensors" of foreign and endogenous signals.

Authors:  Daniel W Nebert
Journal:  Prog Lipid Res       Date:  2017-06-09       Impact factor: 16.195

5.  Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.

Authors:  Lucia F Jorge-Nebert; Ge Zhang; Keith M Wilson; Zhengwen Jiang; Randall Butler; Jack L Gluckman; Susan M Pinney; Daniel W Nebert
Journal:  Hum Genomics       Date:  2016-11-28       Impact factor: 4.639

6.  Epigenome-Wide Association Studies (EWAS) in Cancer.

Authors:  Mukesh Verma
Journal:  Curr Genomics       Date:  2012-06       Impact factor: 2.236
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.